AntiShock

Company Overview

Snapshot

Founded in August 2019 by Yokhai Dan (Yagdanov), Rami Shinnawi, and Dmitri Khalilov, AntiShock operates with 1-10 employees. The company has raised $850,000 across one funding round from two investors. In August 2019, AntiShock secured funding from the Israel Innovation Authority and MindUP.

Business overview

AntiShock is a Health Tech & Life Sciences company focused on developing a noninvasive continuous monitoring device. This technology is designed to assess blood vessel flow, enabling physicians to optimize fluid dosage for patients in a personalized manner. The company operates in the medical devices sector, specifically within medical monitors, serving the healthcare industry and providers in markets such as Israel.

Company Intelligence Q&A

What is AntiShock's primary focus?

AntiShock develops a noninvasive continuous monitoring device to assess blood vessel flow, helping physicians optimize personalized fluid dosage.

When was AntiShock founded and by whom?

AntiShock was founded in August 2019 by Yokhai Dan (Yagdanov), Rami Shinnawi, and Dmitri Khalilov.

How much capital has AntiShock raised?

AntiShock has raised $850,000 in total funding.

Which investors participated in AntiShock's funding round?

In August 2019, AntiShock received funding from the Israel Innovation Authority and MindUP.

What is the current operational status of AntiShock?

AntiShock is currently non-active, having ceased operations in August 2024.